One world, one pandemic, many guidelines: management of liver diseases during COVID-19

Gut. 2020 Aug;69(8):1369-1372. doi: 10.1136/gutjnl-2020-321553. Epub 2020 Jun 4.

¹ School of Medicine & Public Health, The University of Newcastle, Callaghan, New South Wales, Australia steven.bollipo@newcastle.edu.au.
² Department of Gastroenterology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
³ Gastroenterology, University of New Mexico, Albuquerque, New Mexico, USA.
⁴ Department of Veterans Affairs, Washington, District of Columbia, USA.
⁵ The Center for Liver Diseases, Sheba Medical Center, Tel Hashomer, Israel.
⁶ Institute of Digestive Disease, Chinese University of Hong Kong, New Territories, Hong Kong.
⁷ Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun-gu, Korea (the Republic of).
⁸ Hepatobiliary Surgery & Liver Transplantation, Manipal Hospitals, Bangalore, Karnataka, India.
⁹ Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, Birmingham, UK.
¹⁰ Department of Digestive Diseases, Complejo Hospitalario de Pontevedra, Pontevedra, Spain.
¹¹ Division of Gastroenterology and Hepatology, School of Medicine, Stanford University, Palo alto, California, USA.

No abstract available

Keywords: hepatobiliary disease; hepatocellular carcinoma; infectious disease; liver cirrhosis; liver transplantation.

MeSH terms